Ratio Speciality Co. issued today, Jan. 27, a prospectus to sell 5 million shares, or 25% of capital, in an initial public ...

Biotech company Metsera, which develops weight-loss drugs and is backed by ARCH Venture Partners, said on Monday that it is ...

The Ministry of Finance is seeking applicants for the SEBI Chairperson post in Mumbai, with applications due by February 17, ...

Here's what's new in Bay Area biz news to start your workweek: tech stocks on wild ride, empty S.F. office buildings, copper ...

The success of the Public Offer and the broad participation of the investing public is both a vindication of, and a vote of ...

Metsera has set its sights on a hefty $289 million IPO as the next-gen obesity biotech seeks to fund a phase 3 trial of its ...

The U.S. IPO market is moving forward with a steady flow of applicants. Investors this week are awaiting the U.S. Fed's ...

Investors typically celebrate IPOs as milestone moments — and potential exit opportunities — for their startups. In an ...

Snag is, Cheniere’s two export terminals are already advanced enough to generate several billion dollars in cash flow, much of which is already flowing in dividends to shareholders. Venture Global is ...

Metsera, a well-funded biotech trying to angle toward the front of the obesity medicine pack, has proposed a $250 million IPO ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...

Czech steam-turbine manufacturer Doosan Skoda Power AS launched an initial public offering, touting an outlook for high ...